The COPCOV Trial’s position statement on “A living WHO guideline on drugs to prevent COVID-19.”
Following WHO recommendations against the use of hydroxychloroquine in the prevention of COVID-19, including its use in controlled trials, we are reviewing the guideline and available evidence. We are concerned that this judgement from the authors of the guideline is scientifically unsound.
A blood atlas of COVID-19 defines hallmarks of disease severity and specificity
Ahern DJ. et al, (2021)
Theory of change: Drama and arts-based community engagement for malaria research and elimination in Cambodia
Ean M. et al, (2021), Wellcome Open Research, 6, 46 - 46
Seroepidemiology of Foot and Mouth Disease using passive surveillance techniques in selected provinces of Lao PDR.
Siengsanan-Lamont J. et al, (2021), Tropical animal health and production, 53